Adelaide ophthalmic device manufacturer Nova Eye Medical is developing a next generation iTrack glaucoma surgical system to reduce operating times. It is also progressing towards a pivotal US study for its 2RT laser therapy for intermediate AMD that could fulfil a distinct gap in a multi-billion-dollar market.
Read More
ACCC concludes investigation, clears Ellex-Lumibird deal
The Australian competition watchdog has cleared Ellex Medical Lasers’s $100 million sale of its laser and ultrasound business to Lumibird, with the transaction now expected to be completed as early as this week.
Read More
Read More
Ellex shareholders approve sale; company to operate under new name
Ellex Medical Lasers shareholders have backed the $100 million sale of the lasers and ultrasound business to Lumibird Group. They also agreed to re-name the company Nova Eye Medical, forming a debt-free entity with a long-term focus on glaucoma therapies.
Read More
Read More
Ellex CEO steps down as company shifts to new business model
Further leadership changes have occurred at Ellex Medical Lasers with the resignation of its interim CEO, as the company prepares to offload its lasers and ultrasound business to focus on higher growth ophthalmic segments.
Read More
Read More